Schedule 13D ownership disclosure

OPIANT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 683750103

Event date: 2018-10-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001628280-18-012395
Form type
SC 13D/A
Filer
OPIANT PHARMACEUTICALS, INC.
CIK
CIK 1385508
Filed
Oct 09, 2018
Reporting period
Oct 04, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub